Apellis Pharmaceuticals, Inc.
APLS
$17.97
$0.080.45%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.41% | 18.96% | 1.83% | 8.63% | 17.04% |
| Total Receivables | 35.86% | 24.89% | -25.78% | -10.27% | 21.04% |
| Inventory | 75.50% | -4.27% | -25.25% | -46.42% | -49.29% |
| Prepaid Expenses | 0.07% | 16.24% | 14.41% | -3.44% | 10.65% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 159.54% | 171.35% | 85.13% | -19.58% | -39.50% |
| Total Current Assets | 28.63% | 18.80% | -12.14% | -10.32% | 2.95% |
|
|
|||||
| Total Current Assets | 28.63% | 18.80% | -12.14% | -10.32% | 2.95% |
| Net Property, Plant & Equipment | 4.56% | 5.91% | -16.88% | -7.42% | -9.74% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -47.43% | -2.38% | 101.33% | 4,606.93% | 5,787.09% |
| Total Assets | 21.49% | 17.39% | -9.19% | -2.96% | 12.21% |
|
|
|||||
| Total Accounts Payable | 47.25% | -9.66% | 41.73% | 106.39% | 2.81% |
| Total Accrued Expenses | 18.45% | 0.35% | 13.21% | 14.54% | 9.68% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,391.91% | 1,381.20% | 19.39% | 10.98% | 4.84% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 74.44% | 46.15% | 18.62% | -17.15% | -25.08% |
|
|
|||||
| Total Current Liabilities | 74.44% | 46.15% | 18.62% | -17.15% | -25.08% |
| Long-Term Debt | -20.13% | -20.16% | -0.69% | 386.98% | 386.74% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 17.12% | 19.88% | -25.01% | -5.98% | -10.94% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -0.87% | -66.86% | -22.78% | -99.16% | -96.71% |
| Total Liabilities | 7.40% | -1.08% | 3.89% | 13.77% | 10.49% |
|
|
|||||
| Common Stock & APIC | 3.61% | 3.65% | 3.72% | 3.80% | 7.63% |
| Retained Earnings | 0.74% | 1.50% | -7.76% | -7.70% | -6.97% |
| Treasury Stock & Other | 36.43% | 23.57% | 23.59% | 13.36% | 6.61% |
| Total Common Equity | 61.96% | 69.18% | -40.87% | -38.42% | 17.49% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 61.96% | 69.18% | -40.87% | -38.42% | 17.49% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 61.96% | 69.18% | -40.87% | -38.42% | 17.49% |
|
|
|||||